NCT01594073View on ClinicalTrials.gov

Evaluation of Novel Biomarkers to Improve Risk Stratification and Patient Selection in Implantable Cardioverter-defibrillator (ICD) Therapy

CompletedOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

August 31, 2019

Conditions
Ventricular ArrhythmiasCardiac Death
Trial Locations (1)

30625

Hannover Medical School, Hanover

All Listed Sponsors
lead

Hannover Medical School

OTHER

NCT01594073 - Evaluation of Novel Biomarkers to Improve Risk Stratification and Patient Selection in Implantable Cardioverter-defibrillator (ICD) Therapy | Biotech Hunter | Biotech Hunter